[Vinorelbine in patients with malignant pleural mesothelioma--a phase II study].
Ost
E
E
Illiger
H J
HJ
D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D008654:Mesothelioma / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D010997:Pleural Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011788:Quality of Life; D016896:Treatment Outcome; D014747:Vinblastine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000077235:Vinorelbine
D014747:Vinblastine; D000077235:Vinorelbine